OC - platform subscription to support technology transfer program commercial assessment leads
Active Purchase Order Awarded
- Contract number
- 75F40126P00379
- Awardee
-
Tradespace Inc. UEI UQ4QBB269XN5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $22,000
Award facts
- Opportunity
-
- 75F40126Q00438 Solicitation number
- Contract value 27% obligated
-
- $22,000.00 Current, with exercised options
- $82,000.00 Potential, with all options
- Completion date 2% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 513210 Software Publishers
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94110, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to Tradespace Inc. for platform subscription services supporting its Technology Transfer Program commercial assessment initiative, with a ceiling value of $82,000 and an award date of September 23, 2026.
The order is a sole-source acquisition for subscription-based access to an intellectual property lifecycle management and market intelligence platform. Tradespace is a self-certified small disadvantaged business. Performance takes place in San Francisco, California, with place of performance for the FDA listed as Silver Spring, Maryland. The platform provides real-time market intelligence integrated with patent and IP portfolio analytics, with proprietary AI models designed to assess commercial marketability of FDA-developed inventions. Deliverables include platform access for two authorized FDA users, onboarding and live virtual training on platform navigation and commercialization workflows, continuous access to updated market intelligence data, and dedicated technical support during standard business hours, Monday through Friday. The order covers a one-year base period (September 30, 2026 through September 29, 2027) with three optional one-year renewal periods extending through September 29, 2030. The underlying solicitation (75F40126Q00438) closed September 22, 2026.
Quick answers
Who was awarded contract 75F40126P00379?
75F40126P00379 was awarded to Tradespace Inc. by Food and Drug Administration (Department of Health and Human Services) on September 23, 2026.
How much is contract 75F40126P00379 worth?
The government has obligated $22,000 on 75F40126P00379. Its potential value, with all options, is $82,000.
Was contract 75F40126P00379 competed?
The extent of competition for 75F40126P00379 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award